NCT04007887 (EDUCATE) is a NA clinical trial of Adult education program in Myocardial Infarction, sponsored by National and Kapodistrian University of Athens.

Who is sponsoring NCT04007887?

NCT04007887 is sponsored by National and Kapodistrian University of Athens.

What drugs are being tested in NCT04007887?

Interventions in NCT04007887: Adult education program.

What condition does NCT04007887 study?

NCT04007887 studies Myocardial Infarction.

Is NCT04007887 still recruiting?

NCT04007887 is currently status unknown. Last updated 30 July 2019.

Last reviewed 2019-07-30 · How we verify

NCT04007887: EDUCATE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of an Adult EDUcation Program on CArdiovascular ouTcomEs in Post-myocardial-infarction Patients

Status unknown NA Last updated 30 July 2019

What this trial tests

NA trial testing Adult education program in Myocardial Infarction in 320 participants. Status unknown.

Timeline

15 October 2017

Primary endpoint
31 December 2019

30 June 2020

Quick facts

Lead sponsor	National and Kapodistrian University of Athens
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	320
Start date	15 October 2017
Primary completion	31 December 2019
Estimated completion	30 June 2020
Sites	1 location across Greece

Drugs / interventions tested

Adult education program

Conditions studied

Myocardial Infarction — all drugs for Myocardial Infarction →

Sponsor

National and Kapodistrian University of Athens

Who can join

Adults 18 to 80, any sex, with Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A non-MD-led adult education program consisting in 10 one-hour sessions designed to provide information and motivation will be offered to patients who have recently been hospitalized for acute myocardial infarction (STEMI and NSTEMI), regarding the management of their treatment and strategies to aggressively optimize control of cardiovascular risk factors.. The intervention arm will be compared to a control group of patients treated with usual care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A stand-alone structured educational programme after myocardial infarction: a randomised study.
Giannopoulos G, Karageorgiou S, Vrachatis D, Anagnostopoulos I, et al · · 2021 · cited 4× · PMID 33483355 · DOI 10.1136/heartjnl-2020-318414

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
NCT07402642 — Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome · NA · recruiting
NCT07301034 — A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, · Phase 3 · recruiting
NCT07142265 — Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients · recruiting
NCT07138911 — Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity · NA · recruiting

Other National and Kapodistrian University of Athens trials

Trials by the same sponsor.

NCT07295964 — Accuracy of Intraoral Scan Post-processing Methods: A Clinical Trial · NA · not yet recruiting
NCT07351981 — TcPRF for Knee Osteoarthritis · NA · enrolling by invitation
NCT07477496 — Recurrence and Anal Fistula Patient Reported Outcomes Trial · recruiting
NCT07295899 — Assessing the Influence of Implant Scanning Techniques on the Accuracy of Maxillary Complete-Arch Digital Scans for Impl · not yet recruiting
NCT06903130 — Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sN · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04007887 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National and Kapodistrian University of Athens
Last refreshed: 30 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04007887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing